Lineage, Inc. Common Stock (LINE)vsUrban Edge Properties (UE)
LINE
Lineage, Inc. Common Stock
$37.40
-0.32%
REAL ESTATE · Cap: $9.41B
UE
Urban Edge Properties
$20.11
+0.55%
REAL ESTATE · Cap: $2.76B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 1003% more annual revenue ($5.37B vs $486.99M). UE leads profitability with a 14.0% profit margin vs -3.1%. UE earns a higher WallStSmart Score of 53/100 (C-).
LINE
Avoid35
out of 100
Grade: F
UE
Buy53
out of 100
Grade: C-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 31.4%
Reasonable price relative to book value
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Premium valuation, high expectations priced in
Elevated debt levels
Expensive relative to growth rate
Earnings declined 69.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : UE
The strongest argument for UE centers on Operating Margin, Price/Book.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : UE
The primary concerns for UE are P/E Ratio, Debt/Equity, PEG Ratio.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while UE is a value play — different risk/reward profiles.
UE carries more volatility with a beta of 0.99 — expect wider price swings.
UE is growing revenue faster at 7.6% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
UE scores higher overall (53/100 vs 35/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Urban Edge Properties
REAL ESTATE · REIT - RETAIL · USA
Urban Edge Properties is a NYSE-listed real estate investment trust focused on managing, acquiring, developing and remodeling retail real estate in urban communities, primarily in the New York metropolitan region.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?